At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
We seek a collaborative and highly innovative computational and systems biology researcher to join our Predictive Sciences team and develop novel computational and screening strategies that originate, elucidate, and prioritize our next-generation targeted protein degradation therapies in both hematological and solid tumor indications.
Working alongside Research & Early Development colleagues in the BMS Oncogenesis Thematic Research Center, Protein Homeostasis Thematic Center of Excellence, Sequencing Research and other teams in the global Informatics and Predictive Sciences (IPS) department, the successful applicant will play a key scientific role in the systematic profiling and characterization of one of the world’s most advanced degrader compound libraries and in matching novel compound activities to cancer patient states that are challenging to drug using conventional approaches.
This role offers the opportunity to directly impact the origination and delivery of transformational therapies in key diseases of unmet medical need by innovating and applying leading computational research approaches. Strong interest in the inter-disciplinary application of computational research to empower complex life sciences and therapeutic development objectives is imperative.